8-K

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549
                                  ------------
                                    FORM 8-K
                                  ------------
                                 CURRENT REPORT

                       Pursuant to Section 13 or 15(d) of
                       The Securities Exchange Act of 1934

                Date of Report (Date of Earliest Event Reported):
                                  May 29, 2003
                           USANA HEALTH SCIENCES, INC.

             (Exact name of registrant as specified in its charter)

                           Commission File No. 0-21116

        Utah                                               87-0500306
(State or other jurisdiction of                   (IRS Employer Identification
     incorporation)                                          Number)

                           3838 West Parkway Boulevard
                           Salt Lake City, Utah 84120
               (Address of principal executive offices, Zip Code)

       Registrant's telephone number, including area code: (801) 954-7100

   Former name or former address, if changed since last report: Not Applicable







Item 9.  Regulation FD Disclosure

On May 28, 2003, USANA Health Sciences, Inc. announced to distributors the
definitive date of the company's opening in Korea. On May 29, 2003, the company
issued a press release to disclose that it would open its Korean operations on
July 14, 2003, consistent with the company's earlier statements that the opening
would occur during the third quarter of fiscal year 2003. A copy of the press
release is furnished herewith as Exhibit 99.1 to this Form 8-K and is
incorporated herein by reference.

The information in this Current Report is being furnished and shall not be
deemed "filed" for the purposes of Section 18 of the Securities and Exchange Act
of 1934, as amended, or otherwise subject to the liabilities of that Section.
The information in this Current Report shall not be incorporated by reference
into any registration statement or other document pursuant to the Securities Act
of 1933, as amended. The furnishing of the information in this Current Report is
not intended to, and does not, constitute a representation that such furnishing
is required by Regulation FD or that the information this Current Report
contains is material investor information that is not otherwise publicly
available.






                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                    USANA HEALTH SCIENCES, INC.




                                    By:  /s/ Gilbert A. Fuller
                                       ----------------------------------------
                                    Gilbert A. Fuller, Chief Financial Officer

Date: June 2, 2003

EX-99

For more information contact:                    Riley Timmer
                                                 USANA Health Sciences, Inc.
                                                 Investor Relations Analyst
                                                 (801) 954-7100
                                                 investor.relations@us.usana.com


                USANA Announces Official Date For Entering Korea

May 29, 2003 -- USANA Health Sciences, Inc., (NASDAQ: USNA) announces definitive
plans to open its full-service, South Korean headquarters and walk-in
distribution center in Seoul on July 14, 2003.

     Commenting on the announcement, Dave Wentz, President of USANA, said,
"We're pleased that the preparations for this market launch have progressed
smoothly enough for us to open the market in the front end of our previously
announced window. We are excited about the enthusiasm we are seeing from our
Associates as they anticipate the opening of the Korean market.

     "South Korea will be the 10th country where USANA products are sold and
distributed," Mr. Wentz continued. "According to the World Federation of Direct
Selling Associations, South Korea represents the third largest market for direct
sales, with yearly revenues in excess of $4.6 billion in 2002."

USANA develops and manufactures high quality nutritional, personal care, and
weight management products that are sold directly to Preferred Customers and
Associates throughout the United States, Canada, Australia, New Zealand, Hong
Kong, Japan, Taiwan and the United Kingdom. More information on USANA can be
found at http://www.usanahealthsciences.com.

This press release contains forward-looking statements within the meaning of
Section 27A of the Securities Act and Section 21E of the Securities Exchange
Act. Actual results could differ materially from those projected in the




forward-looking statements, which involve a number of risks and uncertainties,
including reliance upon the Company's independent Associate network, government
regulation of products, manufacturing and marketing, and risks associated with
international expansion. These statements and the other contents of this release
should be considered in conjunction with the warnings and cautionary statements
contained in USANA's most recent filings with the Securities and Exchange
Commission on Forms 10-Q and 10-K.